查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2089005

尿道結石治療器械市場：2026-2032年全球市場預測（按器械類型、治療方法、器械材料、應用和最終用戶分類）

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於治療尿道結石的設備市場規模將成長至 18.1 億美元，複合年成長率為 5.96%。

主要市場統計數據
基準年 2025 12.1億美元
預計年份：2026年 12.7億美元
預測年份 2032 18.1億美元
複合年成長率 (%) 5.96%

用於治療尿道結石的器械旨在解決嚴重的醫療負擔，涵蓋腎結石、輸尿管結石、膀胱結石和尿道結石。脫水、肥胖、糖尿病、高鈉攝取、液體攝取不足以及結石復發等已知的危險因子是推動治療需求的主要因素。流行病學研究表明，在過去幾十年中，許多國家的腎結石發病率呈上升趨勢，且結石復發率仍然很高，因此，持久有效、微創且經濟的治療方法成為醫院和門診手術中心的首要任務。

使用的醫療設備包括輸尿管鏡、钬雷射和鈰雷射碎石系統、取石籃、導管鞘套、輸尿管支架、腎鏡、經皮腎鏡取石術器械以及體外震波碎石（ESWL）平台。這些器械的廣泛應用得益於以下幾個方面：指南支持的內視鏡結石治療的普及、住院時間的縮短、視野的改善、再次治療需求的減少，以及有助於提高結石清除率並縮短手術時間的醫療設備醫療設備的出現。

尿道結石治療設備領域的變革性變化

隨著尿道結石治療方式從開放性手術轉向微創內視鏡治療，泌尿系統結石治療器械市場格局正在重塑。軟性拋棄式輸尿管鏡降低了交叉感染和因維修而導致的運作風險，而高功率雷射系統、铥光纖雷射平台和先進光纖則提高了結石碎裂和粉碎的效率。此外，醫院也優先採用整合成像、灌注控制、抽吸輔助通路和數位化工作流程工具，以幫助規範手術流程，提高手術品質。

人工智慧（AI）的累積影響

人工智慧 (AI) 正開始影響尿道結石，尿道結石診斷和治療計劃到後續觀察。 AI 驅動的影像工具可以輔助進行結石檢測、測量、密度估計、分割以及 CT 掃描的自動報告，而 CT 掃描已被廣泛認為是疑似泌尿系統結石的標準影像學檢查方法。這些功能可以幫助臨床醫生決定是否後續觀察、藥物治療、輸尿管鏡檢查、體外震波碎石術或經皮腎鏡取石術取石術。

主要區域趨勢

隨著中國、印度、日本、韓國和澳洲等國對泌尿內泌尿系統系統、私人醫院網路和先進影像技術的投資，亞太地區持續擴張。龐大的患者群體、部分地區的高溫、都市區飲食結構的改變以及代謝性疾病負擔的加重，都推動了對輸尿管鏡和雷射碎石術解決方案的持續需求。北美地區仍然是技術密集型地區，以美國和加拿大主導，擁有成熟的泌尿系統體系、完善的醫保報銷機制、門診手術中心以及早期採用一次性內鏡，這些都為先進醫療設備的普及應用提供了支持。

主要群體分析

東協市場的特點是泌尿內泌尿系統治療的可近性不斷提高，儘管各地區的情況有所不同。新加坡、泰國、馬來西亞、印尼、越南和菲律賓的採購模式各不相同，這與公立和私立醫療體系的組成、專家的分佈以及醫院的投資週期有關。海灣合作理事會（GCC）國家具有重要的戰略意義，因為高溫、脫水風險以及對先進醫院的持續投資為切開取石系統、輸尿管鏡、支架、導管鞘套和一次性手術用品的採購創造了有利條件。

主要國家的概況

美國在先進尿道結石治療設備的採用方面主導，這得益於其龐大的手術量、不斷擴大的門診服務、內視鏡結石治療的廣泛應用，以及對數位輸尿管鏡和雷射平台的早期採用。加拿大強調實證醫學的採購和各省之間的公平獲取，而墨西哥的私部門對微創泌尿系統治療的需求日益成長。巴西是拉丁美洲最大的市場，這得益於其眾多的專科醫療中心、不斷成長的醫院投資以及對輸尿管鏡、雷射碎石術和經皮碎石術日益成長的需求。

為行業領導者提供的實用建議

產業領導者應優先考慮那些在結石清除率、手術效率、安全性、感染控制、耐用性和生命週期成本方面能夠帶來可衡量改進的醫療設備。產品系列應將可重複使用的配件（例如雷射光纖、取石籃、入路鞘套、輸尿管支架、腎臟造瘻器和沖洗液）與大型設備結合，並為泌尿系統、護理師和手術室團隊提供清晰的訓練計畫。

調查方法

本執行摘要基於對二手研究、臨床指南審查、監管資訊以及來自泌尿系統協會、政府衛生機構、同行評審文獻、醫院採購趨勢和醫療設備監管機構的公開資訊的三角檢驗。資訊來源包括美國泌尿系統協會 (AUA) 和歐洲泌尿系統協會 (EAU) 的既定臨床指南、關於泌尿道結石發病率和復發率的流行病學文獻，以及美國 FDA 要求和歐盟醫療設備法規等法規結構。

結論

尿道結石治療器械市場正朝著微創、數位化和實證醫學的方向發展。結石負擔日益加重、疾病復發率上升以及對高效門診治療需求的成長，持續推動著輸尿管鏡、雷射碎石術、取石器械、支架、經皮腎鏡取石術器械及相關內視鏡泌尿系統平台的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：尿道結石治療器械市場：依器械類型分類

  • 導管導引線
  • 破碎設備
  • 支架
  • 輸尿管鏡

第8章：尿道結石治療器材市場：依治療方法分類

  • 體外震波碎石術
  • 體內取石術
  • 經皮腎鏡取石術

第9章：尿道結石治療器械市場：依器械材料分類

  • 金屬基元件
  • 基於聚合物的裝置

第10章：尿道結石治療器械市場：依應用領域分類

  • 膀胱結石
  • 腎結石
  • 輸尿管結石

第11章：尿道結石治療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：尿道結石治療器械市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：尿道結石治療器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：尿道結石治療器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Advanced MedTech Holdings
  • AKSM, Ltd.
  • Avvio Medical, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Calyxo Inc.
  • Coloplast A/S
  • Cook Group Incorporated
  • DirexGroup
  • Dornier MedTech GmbH
  • Dyne Medical Group Inc.
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Elmed Lithotripsy Systems
  • EndoTheia, Inc.
  • Karl Storz GmbH & Co. KG
  • Nissha Medical Technologies
  • Olympus Corporation
  • Quanta System SpA
  • Richard Wolf GmbH
  • Siemens Healthineers
  • SonoMotion
  • Teleflex Incorporated
Product Code: MRR-ED54C46E9009

The Urolithiasis Management Devices Market is projected to grow by USD 1.81 billion at a CAGR of 5.96% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.21 billion
Estimated Year [2026] USD 1.27 billion
Forecast Year [2032] USD 1.81 billion
CAGR (%) 5.96%

Urolithiasis management devices address a high-burden clinical area spanning kidney, ureteral, bladder, and urethral stones. Demand is supported by well-documented risk factors, including dehydration, obesity, diabetes, high dietary sodium intake, low fluid intake, and recurrent stone disease. Epidemiology studies consistently show that kidney stone prevalence has increased over recent decades in many countries, while recurrence remains common, making durable, minimally invasive, and cost-efficient treatment pathways a priority for hospitals and ambulatory surgery centers.

The device landscape includes ureteroscopes, holmium and thulium fiber laser lithotripsy systems, stone retrieval baskets, access sheaths, ureteral stents, nephroscopes, percutaneous nephrolithotomy instruments, and extracorporeal shock wave lithotripsy platforms. Adoption is reinforced by guideline-backed movement toward endoscopic stone treatment, shorter inpatient stays, improved visualization, reduced retreatment needs, and devices that help lower operative time while supporting higher stone-free rates.

Transformative Shifts in the Urolithiasis Devices Landscape

The urolithiasis management devices landscape is being reshaped by the shift from open surgery to minimally invasive endourology. Flexible and single-use ureteroscopes are reducing cross-contamination concerns and repair-related downtime, while high-power laser systems, thulium fiber laser platforms, and advanced fibers improve fragmentation and dusting efficiency. Hospitals are also prioritizing integrated imaging, irrigation control, suction-assisted access, and digital workflow tools that help standardize procedure quality.

A second transformation is occurring in care delivery. More stone procedures are moving into outpatient and same-day settings where device reliability, fast turnover, sterilization efficiency, and predictable supply are essential. Procurement decisions increasingly evaluate total cost of ownership, device reprocessing requirements, surgeon learning curves, service support, and compatibility with existing operating room infrastructure rather than unit price alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence urolithiasis management across diagnosis, procedure planning, and follow-up. AI-enabled imaging tools can support stone detection, measurement, density estimation, segmentation, and automated reporting on CT, which is widely regarded as the reference imaging modality for suspected urinary stones. These capabilities may help clinicians select between surveillance, medical expulsive therapy, ureteroscopy, shock wave lithotripsy, or percutaneous nephrolithotomy.

The cumulative impact of AI will be strongest where it connects imaging, electronic health records, device data, and recurrence-risk models. Predictive analytics can identify patients at higher risk of repeat stones, while automated documentation and operative analytics can improve quality reporting, benchmarking, and procedure planning. Industry leaders should treat AI as a clinical decision-support layer that must be validated, explainable, cybersecurity-ready, and integrated within regulated medical device frameworks.

Key Regional Insights

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in endourology capacity, private hospital networks, and advanced diagnostic imaging. Large patient pools, hot climates in several subregions, urban dietary shifts, and increasing metabolic disease burden support durable demand for ureteroscopic and laser lithotripsy solutions. North America remains a technology-intensive region led by the United States and Canada, where established urology practices, reimbursement access, ambulatory surgery centers, and early adoption of single-use scopes support advanced device utilization.

Europe benefits from guideline-driven care, strong academic urology centers, and broad adoption of minimally invasive stone treatment across Germany, France, Italy, Spain, and the United Kingdom. Latin America is gaining momentum through Brazil and Mexico, though adoption varies with reimbursement, public-sector funding, hospital infrastructure, and specialist access. The Middle East shows strong demand in GCC countries due to high stone prevalence associated with climate, dehydration, and lifestyle risk factors, while Africa presents a long-term access opportunity where affordability, training, equipment maintenance, and infrastructure remain decisive.

Key Group Insights

ASEAN markets are characterized by uneven but rising access to endoscopic urology, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing different procurement patterns tied to public-private healthcare mix, specialist distribution, and hospital investment cycles. GCC countries are strategically important because high temperatures, dehydration risk, and sustained investments in advanced hospitals create favorable conditions for lithotripsy systems, ureteroscopes, stents, access sheaths, and procedure-specific disposables.

The European Union offers regulatory harmonization through the Medical Device Regulation, but manufacturers must account for stronger clinical evidence expectations, post-market surveillance, and traceability requirements. BRICS countries represent scale, local manufacturing potential, and price-sensitive tenders, especially in China, India, Brazil, and South Africa, while Russia presents procurement and supply-chain complexity. G7 markets remain innovation leaders with high specialist density, sophisticated reimbursement pathways, and strong procedure standardization, while NATO-aligned countries often benefit from mature procurement systems, training infrastructure, and cross-border clinical collaboration.

Key Country Insights

The United States leads in advanced urolithiasis management device adoption due to high procedural volumes, ambulatory care expansion, broad use of endoscopic stone management, and early uptake of digital ureteroscopy and laser platforms. Canada emphasizes evidence-based procurement and equitable access across provinces, while Mexico is expanding private-sector demand for minimally invasive urology. Brazil is Latin America's largest opportunity, supported by specialist centers, growing hospital investment, and rising demand for ureteroscopy, laser lithotripsy, and percutaneous stone procedures.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong use of guideline-based endoscopic stone management, with Germany particularly important for device quality expectations, hospital purchasing power, and advanced surgical infrastructure. Russia remains relevant but faces procurement complexity and supply-chain constraints. China and India provide high-volume growth potential as hospital infrastructure expands, imaging access improves, and domestic manufacturers scale. Japan, South Korea, and Australia favor advanced, quality-focused technologies supported by sophisticated urology communities, strong clinical training, and well-developed regulatory systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize devices that demonstrate measurable improvements in stone-free rates, operative efficiency, safety, infection control, durability, and lifecycle cost. Product portfolios should combine capital equipment with recurring-use accessories, including laser fibers, baskets, access sheaths, ureteral stents, nephrostomy tools, and irrigation solutions, while offering clear training pathways for urologists, nurses, and operating room teams.

Manufacturers should localize market access strategies by region, strengthen clinical evidence generation, and prepare for stricter post-market data expectations. Partnerships with hospitals, ambulatory surgery centers, and academic urology programs can accelerate adoption and improve procedural consistency. Organizations that integrate AI-ready imaging data, service analytics, cybersecurity controls, and procedure support into compliant platforms will be better positioned for premium differentiation.

Research Methodology

This executive summary is built on secondary research, clinical guideline review, regulatory intelligence, and triangulation of publicly available information from urology associations, government health agencies, peer-reviewed literature, hospital procurement trends, and medical device regulatory bodies. Sources considered include established clinical guidance from the American Urological Association and European Association of Urology, epidemiological literature on stone disease incidence and recurrence, and regulatory frameworks such as U.S. FDA requirements and the EU Medical Device Regulation.

The methodology evaluates demand drivers, technology shifts, care settings, competitive positioning, regional access conditions, reimbursement indicators, and compliance requirements. Insights are validated through cross-comparison of clinical, commercial, and policy evidence to ensure that conclusions remain data-backed, practical, and relevant for decision-makers in urolithiasis management devices.

Conclusion

The urolithiasis management devices market is moving toward minimally invasive, digitally enabled, and evidence-driven care. Rising stone burden, recurring disease, and growing demand for efficient outpatient procedures continue to support adoption of ureteroscopy, laser lithotripsy, stone retrieval tools, stents, percutaneous nephrolithotomy instruments, and related endourology platforms.

Competitive advantage will depend on clinical performance, reliability, training support, regulatory readiness, infection prevention, service quality, and total cost of ownership. Companies that align product innovation with regional access realities and AI-enabled clinical workflows can capture sustainable growth while improving patient outcomes across global stone disease care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Urolithiasis Management Devices Market, by Device Type

  • 7.1. Guidewires
  • 7.2. Lithotripters
  • 7.3. Stents
  • 7.4. Ureteroscopes

8. Urolithiasis Management Devices Market, by Treatment Type

  • 8.1. Extracorporeal Shock Wave Lithotripsy
  • 8.2. Intracorporeal Lithotripsy
  • 8.3. Percutaneous Nephrolithotomy

9. Urolithiasis Management Devices Market, by Device Material

  • 9.1. Metal-Based Devices
  • 9.2. Polymer-Based Devices

10. Urolithiasis Management Devices Market, by Application

  • 10.1. Bladder Stones
  • 10.2. Kidney Stones
  • 10.3. Ureteral Stones

11. Urolithiasis Management Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Urolithiasis Management Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Urolithiasis Management Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Urolithiasis Management Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Advanced MedTech Holdings
  • 16.2. AKSM, Ltd.
  • 16.3. Avvio Medical, Inc.
  • 16.4. Becton, Dickinson and Company
  • 16.5. Boston Scientific Corporation
  • 16.6. Calyxo Inc.
  • 16.7. Coloplast A/S
  • 16.8. Cook Group Incorporated
  • 16.9. DirexGroup
  • 16.10. Dornier MedTech GmbH
  • 16.11. Dyne Medical Group Inc.
  • 16.12. E.M.S. Electro Medical Systems S.A.
  • 16.13. EDAP TMS SA
  • 16.14. Elmed Lithotripsy Systems
  • 16.15. EndoTheia, Inc.
  • 16.16. Karl Storz GmbH & Co. KG
  • 16.17. Nissha Medical Technologies
  • 16.18. Olympus Corporation
  • 16.19. Quanta System S.p.A.
  • 16.20. Richard Wolf GmbH
  • 16.21. Siemens Healthineers
  • 16.22. SonoMotion
  • 16.23. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LITHOTRIPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LITHOTRIPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LITHOTRIPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URETEROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETEROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URETEROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRACORPOREAL LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLADDER STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLADDER STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLADDER STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KIDNEY STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KIDNEY STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KIDNEY STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETERAL STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETERAL STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETERAL STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 209. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)